| Old Articles: <Older 42441-42450 Newer> |
|---|
 |
The Motley Fool
July 23, 2010 |
The Closing Bell Toward the goal of amusing, we are pleased to present Jack Guinan's weekly cartoon, "The Closing Bell."  |
The Motley Fool
July 23, 2010
Dave Mock |
3 Reasons to Sell Energy Conversion Devices Today Not everyone is on the buy side for this solar products maker.  |
The Motley Fool
July 23, 2010
Anders Bylund |
Why ARM Beats Rambus Two licensing experts in related markets have similar goals but very different personalities. Both companies focus on making chips run faster and cooler on less electrical power, and they have provided investors with periods of volatile returns. |
The Motley Fool
July 23, 2010
Seth Jayson |
Show Me the Money, Wal-Mart All cash flow is not created equal. |
The Motley Fool
July 23, 2010
Alyce Lomax |
Underworked and Overpaid Today, White House pay czar Kenneth Feinberg said that from October 2008 through February 2009, 17 major financial companies that received bailout money from the government subsequently overpaid their executives. |
The Motley Fool
July 23, 2010
Jim Mueller |
Buy, Sell, or Hold Altria? Which position should you take? |
The Motley Fool
July 23, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Canaccord pulls the plug on Netflix -- and rightly so. |
The Motley Fool
July 23, 2010
Jordan DiPietro |
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider? |
The Motley Fool
July 23, 2010
Luke Timmerman |
Momenta Gets FDA Green Light for Generic Anti-Clotting Drug The FDA says "yes" to Momenta Pharmaceuticals. |
The Motley Fool
July 23, 2010
Mike Pienciak |
Drink In Coca-Cola's Renewed Growth With North American beverage volumes in the black, the company's finally firing on all cylinders. |
| <Older 42441-42450 Newer> Return to current articles. |
